Max Healthcare Institute Limited has completed the allotment of 51,287 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The Nomination & Remuneration Committee approved this allotment on May 1, 2026, at 6:56 pm IST, as part of the company's employee incentive program.

Share Allotment Details

The allotment involves 51,287 equity shares with a face value of ₹10 each, issued as fully paid-up shares to eligible employees who exercised their vested stock options. The exercise price was set at ₹350 per equity share, with a premium of ₹340 per share.

Impact on Share Capital

The allotment has resulted in an increase in the company's paid-up equity share capital. The shares have been issued in dematerialized form with distinctive numbers ranging from 97,31,92,503 to 97,32,43,789.

Regulatory Compliance and Filing Details

The allotment has been made in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company filed the initial statement under regulation 10(b) with the stock exchanges on September 29, 2022, receiving filing numbers DCS/IPO/MJ/ESOP-IP/2511/2022-23 from BSE and NSE/LIST/32765 from NSE.

Share Characteristics

The newly allotted equity shares are identical in all respects to the existing equity shares of the company. No lock-in provisions apply to these shares, and no listing fees are payable for this allotment. The company has noted that this allotment is not material in nature under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure regarding this allotment will be hosted on the company's website at www.maxhealthcare.in , ensuring transparency and compliance with regulatory requirements. The communication was signed by Dhiraj Aroraa, SVP - Company Secretary and Compliance Officer, and submitted to both BSE Limited and National Stock Exchange of India Limited.

Max Healthcare Institute Limited has received a significant relief in the form of a GST rectification order that withdraws the entire demand of ₹55,20,45,266 raised against the company. The rectification order was issued on April 21, 2026, by the Office of the GST Officer, Ward 96, Zone 9, Department of Trade and Taxes, New Delhi, and was received by the company on the same day at 12:27 PM IST.

GST Demand Withdrawal Details

The rectification order represents a complete reversal of the earlier GST demand that was raised against Max Healthcare Institute. The company has provided detailed disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Background and Resolution

This development follows the company's earlier intimation dated December 30, 2025, wherein Max Healthcare Institute had informed about receiving an order from the Office of the GST Officer alleging excess availment of Input Tax Credit. The original order was issued by Ward-92&96, Department of Trade and Taxes, GNCT of Delhi.

Upon due consideration of the submissions made by the company, the GST authority accepted the rectification application filed by Max Healthcare Institute. The authority's decision to withdraw the entire demand indicates that the company's submissions were found to be satisfactory and compliant with GST regulations.

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing both the National Stock Exchange of India Limited and BSE Limited about this development. The disclosure has also been hosted on the company's website at www.maxhealthcare.in as part of its transparency commitments.

The rectification order represents a positive outcome for Max Healthcare Institute, eliminating a significant financial liability that was previously under dispute. The company's proactive approach in filing the rectification application and providing necessary submissions to the GST authorities has resulted in the complete withdrawal of the demand.